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Abstract
Background—We posit that cell-mediated drug delivery can improve transport of therapeutic
enzymes to the brain and decrease inflammation and neurodegeneration induced during
Parkinson’s disease. Our prior work demonstrated that macrophages loaded with nanoformulated
catalase (“nanozyme”) protect the nigrostriatum in a murine model of Parkinson’s disease.
Packaging of catalase into block ionomer complex with a synthetic polyelectrolyte block
copolymers protects the enzyme degradation in macrophages.
Methods—We examined relationships between the composition and structure of block ionomer
complexes, their physicochemical characteristics, and loadings, release rates, and catalase activity
in bone marrow-derived macrophages.
Results—Formation of block-ionomer complexes resulted in improved aggregation stability.
Block ionomer complexes with ε-polylisine, and poly-L-glutamic acid -poly(ethylene glycol)
demonstrated the least cytotoxicity and high loading and release rates, however, did not efficiently
protect catalase inside macrophages.
Conclusion—nanozymes with polyethyleneimine- and poly(L-lysine)10-poly(ethylene glycol)
provided the best protection of enzymatic activity for cell-mediated drug delivery.
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Cell-based drug carriage of nanoformulated drugs and proteins has shown promise in early
efforts aimed to improve central nervous system (CNS) drug delivery. Specifically, it is one
promising avenue for translational research efforts seeking ways to combat the ravages of
neurodegenerative disease [1]. The system rests in the abilities of blood borne macrophages
to carry a range of neuroprotective, immune modulatory, and antimicrobial drugs, acting as
Trojan horses, to cross the blood brain barrier (BBB) and affecting ongoing disease at action
sites [2-5]. Specific drug carriage inside inflammatory cells rests with commonalities of
inflammatory processes that underlie degenerative, infectious, and metabolic disorders of
the CNS that include Alzheimer’s and Parkinson’s diseases (AD and PD), amyotrophic
lateral sclerosis, Prion disease, meningitis, encephalitis, multiple sclerosis, hepatic
encephalopathy, and human immunodeficiency virus (HIV)-associated neurocognitive
impairment (HAND) [6]. Such CNS inflammation is characterized by chemokine and
cytokine-mediated leukocyte recruitment to the site of disease by processes involving
macrophage diapedesis and chemotaxis [7]. Importantly, macrophages also have a high rate
of endocytosis that allows them to efficiently accumulate micro- and nanoparticles within
intracytoplasmic endosomes and release them through processes that include exocytosis. All
these features make blood borne and tissue macrophages attractive candidates for cell-
mediated delivery of drugs and therapeutic proteins. Particularly, redox enzymes, which are
known to inactivate reactive oxygen species (ROS) and reduce inflammation at the site of
action, can be carried by into a diseased inflamed brain.
Recently our laboratories developed novel CNS drug delivery systems using macrophages
for delivery of the antioxidant enzyme, catalase, in the 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) mouse model of PD [8]. For this system, nanoformulated
catalase was obtained by coupling the enzyme to a cationic block copolymer,
polyethyleneimine-poly(ethylene glycol), leading to a polyion complex micelle. Using
macrophages as a carrier for therapeutic proteins offers several advantages to combat CNS
disease including: i) prolonged plasma drug levels; ii) time-controlled release of the cell
loaded drug; iii) targeted drug transport to the site of disease; and iv) diminished drug
immunogenicity. Indeed, our previous works has demonstrated that BMM loaded with
nanoformulated catalase and injected into MPTP-intoxicated mice reduce
neuroinflammation and attenuate nigrostriatal degeneration [9].
In attempts to improve upon what was previously done we theorized that appropriate drug
nanoformulations for cell-mediated delivery could be best designed by optimization of
loading capacity, enabling sustained release, and realizing efficient preservation of drug
activity within the cell-carriers. Indeed, size, charge and shape of nanoformulated
antiretroviral drugs were shown important for macrophage-based delivery in treating
ongoing HIV-1 disease [1]. Similar results were reported for the monocytes and neutrophil-
mediated delivery of the liposome-encapsulated antifungal agent, chloroquine, against C.
neoformans infection in the mouse brain [5]. In particular, cell-carriers showed preferential
uptake of liposomes containing negatively charged lipids, such as phosphatidylserine [3],
over liposomes that contain only neutral lipids, such as phosphatidylcholine. In addition,
cytotoxicity of nanocontainers, as well as their ability to protect the drug inside cell-carriers,
is also determined by their composition and structure [1].
The present study serves to optimize cell mediated enzyme delivery for therapeutic gain by
improving the preparation and characterization of polyion complexes obtained by coupling
catalase to different block copolymers. This consisted of: a) ionic block (positively-charged:
polyethyleneimine- (PEI), or poly(L-lysine)- (PL); or negatively-charged: poly(L-glutamic
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acid)- (PGLU); and b) non-ionic block, poly(ethylene glycol)- (PEG). Electrostatic
interactions between catalase and the charged copolymer block resulted in the formation of a
insoluble polyion core, while a PEG corona provided stability of nanoparticles in water
solutions. Effects of the length, charge and structure (linear or branched) of the ionic block
on the nanozyme cytotoxicity, kinetics of uptake and release, and ability to protect
enzymatic activity inside the host cells were examined. In addition, polymers with the
similar ionic blocks (PEI or PL) but without PEG block were used to evaluate the role of
PEG corona. All together, the incorporation of catalase in a BIC with cationic block
copolymers, polyethyleneimine-poly(ethylene glycol) (PEI50-PEG), or poly(L-lysine)-
poly(ethylene glycol) (PL50-PEG), resulted in formulations with optimal protection and
sustained enzyme release of active catalase from macrophage carriers.
MATERIALS & METHODS
Reagents
Lipopolysaccharides (LPS), MPTP, polyethylenimine (PEI50) (2K, branched, 50% aq.
solution), pronase, sulforhodamine-B (SRB), sodium dodecylsulfate (SDS), Sephadex G-25,
Triton X-100, and trypsin, were purchased from Sigma-Aldrich, St. Louis, MO. Catalase
from bovine liver erythrocytes was provided by Calbiochem (San Diego, CA).
Methoxypolyethylene glycol epoxy (Me-PEG-epoxy) was purchased from Shearwater
Polymer Inc. (Huntsville, AL). PEI50-PEG was synthesized using a modified procedure [10]
by conjugation of PEI50 and Me-PEG-epoxy. Block copolymers PL10-PEG, PL30-PEG,
PL50-PEG, and PGLU50-PEG were custom synthesized by Alamanda Polymers (Madison,
AL). Epsilon polylisine (EPL) was purchased in Tecoland Co. (Edison, NJ). Metal chelators,
DETC and deferoxamine were purchased from Noxygen Science Transfer and Diagnostics
(Denzlingen, Germany). LysoSensor Yellow/Blue DND 160 was obtained from Molecular
Probes (Eugene, OR). Interferon gamma (INT-γ) was purchased from Peprotech Inc.
(RockyHill, N.J.)
Catalase Nanozymes
The polycomplexes were produced by mixing enzymes and block copolymers, which bind
electrostatically to each other and forming nanoparticles with an enzyme-polyion complex
core and PEG corona. Catalase and each block copolymer were separately dissolved in
phosphate-buffered saline (PBS) at room temperature. Pre-calculated volumes of the block
copolymer solution were added drop-by-drop to the enzyme solution to achieve the desired
charge ratio (Z). The +/- charge ratio (Z) was calculated by dividing the amount of
aminogroups in PL10-PEG, PL50-PEG, or PEI50-PEG protonated at pH 7.4 [11] by the total
amount of Gln and Asp in catalase. In the case of PGLU50-PEG/catalase nanozyme, the -/+
charge ratio (Z-/+) was calculated by dividing the number of carboxyl groups of PGLU50-
PEG by the total amount of Arg and Lys in catalase. To obtain a narrow size distribution of
the particles, the nanozymes were filtered through a 20 nm filter before use.
Atomic Force Microscopy (AFM)
Nanozymes were prepared as described at an enzyme concentration of 1 mg/mL. Samples
were diluted 100 × in PBS. A drop of catalase alone or catalase nanozyme dispersion (Z=1)
in PBS was placed on positively charged mica treated with 1-(3-aminopropyl) silatrane
(APS) [12] for 2 minutes, washed with deionized water and dried under an argon flow.
Following additional drying for 15 min in vacuum, the glass slide with the sample was
placed on the AFM stage of the Asylum Research Instrument (Santa Barbara, CA). The
AFM imaging was operated in AC mode in air. The height, amplitude and phase images
were collected. Regular silicon probes with spring constants of 40 N/m and resonance
frequencies of 270-320 kHz were used.
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Image processing and the cross-section analysis were performed using Femtoscan
(Advanced Technologies Center, Moscow, Russia). The height of the particles and their
diameters measured at half-maximal height were obtained from the cross-section analysis.
The volume was approximated by a hemisphere using the equation described in [13]. To
convert the volume data into particle size we used the volume value for Sfi tetramer (124
kDa) bound to DNA as described in [14].
Light Scattering Measurements (DLS)
Effective hydrodynamic diameter and ξ-potential of nanozymes were measured by photon
correlation spectroscopy using the Zetasizer Nano (Malvern, UK) equipped with a 35 mW
solid state laser (658 nm laser) as described [15,16]. Scattered light was detected at a 90°
angle and a temperature of 25° C. Hydrodynamic size was expressed as mean ± SEM of
triplicate measurements. The aggregation stability of the nanoparticles in 10 mM phosphate
buffer was examined over 168 hours.
Cells
Bone marrow-derived macrophages (BMM) were extracted from femurs of C57Bl/6 male
mice 6-7 weeks of age according to previously published protocols [17] and cultured for 12
days in DMEM medium (Invitrogen, Carlsbad, CA) supplemented with 1,000 U/mL
macrophage colony-stimulating factor (MCSF), a generous gift from Wyeth Pharmaceutical,
Cambridge, MA). BMM were collected after 12 – 14 days of culture. Human monocytes
were obtained from leukopaks of healthy donors, purified by countercurrent centrifugal
elutration [18] and cultivated with MCSF as described above.
Bovine brain microvessel endothelial cell (BBMEC) monolayers that retain many of the
morphological and biochemical characteristics of the BBB, such as the formation of tight
junctions and low pinocytic activity [19], were used to reflect BBB function. BBMEC were
isolated from fresh cow brains by enzymatic digestion and density centrifugation and grown
on 96-well plates until confluent (typically 12 days) [20].
Mouse catecholaminergic CATH.a neurons were purchased from American Type Culture
Collection (ATCC, Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented
with 8% normal horse serum (NHS), 4% fetal bovine serum (FBS), and 1% penicillin-
streptomycin. Cultures were maintained in a humidified incubator at 37°C and 5% CO2.
CATH.a neurons were differentiated by adding 1 mM of N6,2’-O-dibutyryladenosine 3’,5’-
cyclic monophosphate sodium salt (dbcAMP, Sigma-Aldrich) to the culture media every
other day for 6-8 days.
Cytotoxicity Assays
To evaluate toxicity of different nanozymes in BMM, CATH.a neurons, or BBMEC, cells
were seeded in 96 well plates at a density of 10,000 cells/well and allowed to reattach
overnight. Following treatment with various concentrations of nanozymes or block
copolymers and catalase alone for two hours at 37°C, the cells were washed with PBS and
cultured for 72 hours in complete media. The survival of the cells was determined using a
standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [21].
To ensure that catalase does not interfere with MTT coloring reaction, sulforhodamine-B
(SRB) cell viability assay was used in parallel experiments.
BMM Accumulation and Release of Nanozymes
Catalase was labeled with rhodamine isothiocyanate (RITC) [8]. BMM grown on 24-well
plates (2.5 × 106 cells/plate) [20,22] were pre-incubated with assay buffer (122 mM NaCl,
25 mM NaHCO3, 10 mM glucose, 3 mM KCl, 1.2 mM MgSO4, 0.4 mM K2HPO4, 1.4 mM
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CaCl2 and 10 mM HEPES) for 20 min. Following preincubation, the cells were treated with
the RITC-labeled enzyme (1 mg/ml) in assay buffer alone or different nanozymes with
various Z ratios for two hours. After incubation, the cells were washed three times with ice-
cold PBS, and solubilized in Triton X100 (1%). For release studies, BMM were loaded with
nanozymes for two hours, washed three times with ice-cold PBS, and then incubated in fresh
media for various time points. Fluorescence in each sample was measured by Shimadzu
RF5000 fluorescent spectrophotometer (λex=580 nm, λem=617 nm). The amount of RITC-
labeled nanozyme was normalized for protein content and expressed in μg of enzyme per mg
of the protein for loading experiments and μg enzyme per ml media as means ± SEM (N =
8). To exclude misinterpretation of results concerning possible degradation of catalase and
accounting for fluorescent probe alone, BMM were incubated with 125I-labeled catalase
nanozymes. Following incubation, BMM with accumulated enzyme were supplemented
with trichloroacetic acid (TCA) for protein precipitation as described [23]. The radioactivity
levels of the cells precipitates were measured on Wizard 3’ 1480 γ-counter (PerkinElmer
Life, Boston, MA).
Antioxidant Activity Measurements
Catalytic activity of catalase alone or nanozymes was measured by three methods:
spectrophotometry, EPR, and Amplex Red assay. The effect of incorporation of catalase into
polyelectrolyte complex on its antioxidant activity was evaluated in a cell-free system. First,
catalase activity in samples was measured using hydrogen peroxide decomposition.
Activities were measured by monitoring the change in absorbance at 240 nm using Lambda
25 UV VIS Spectrophotometer (Perkin Elmer Instruments, Waltham, MA). In particular, 1
mL PBS, pH 7.4, 1-4 μL H2O2 (7.5 – 30 % v/w), and 2 μL catalase (0.06 - 0.5 mg/ml) or
various nanozymes with different Z ratios were added into a cuvette. The initial activity was
10263 U/mg protein for catalase. A linear dependence of the catalytic activity on enzyme
concentrations was observed in the range of 0.1 μg/ml – 1 mg/ml (data not shown).
Furthermore, the stability of catalase in BIC was examined upon incubation of different
nanozymes (0.5 mg/ml catalase) with trypsin (10-5 M), or pronase (2×10-1 mg/ml) for 3
hours at 37°C. Following incubation, the aliquots were subjected for catalytic activity
assessment as described above. Stability of catalase was expressed in residual activity vs.
initial activity of nanozyme. Concentration dependence of catalase enzymatic activity was
studied in a range of 1.7 – 35.2 mM hydrogen peroxide. Apparent kinetic parameters of
different catalase nanozymes were determined for various Z ratios, and calculated using
Lineweaver–Burk plot (or double reciprocal plot) [24].
Next, the ability of catalase nanozyme to scavenge hydrogen peroxide (H2O2) was tested by
EPR spectroscopy in a cell-free system. Samples were prepared with a 200 μM spin probe 1-
hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) and 20 μM H2O2 in 100
μL of a supplemented EPR buffer, called KDD+ buffer (pH 7.4), as previously described
[25]. KDD+ buffer is a Krebs-HEPES buffer consisting of (in mM): 99 NaCl, 4.69 KCl, 2.5
CaCl2, 1.2 MgSO4, 25 NaHCO3, 1.03 KH2PO4, 5.6 D-glucose, 20 HEPES and
supplemented with the metal chelators DETC (5 μM) and deferoxamine (25 μM). For the
experimental groups, 250 ng/ml of free catalase or selected nanozymes (PEI50-PEG/catalase,
PL10-PEG/catalase, and PGLU50-PEG/catalase) with different Z ratios (1, 10, and 20)
incubated for different time points (0, 50, 100, and 150 minutes) at room temperature, and
then were supplemented with 20 μM H2O2 and incubated at RT for 12 minutes before
adding KDD amendments: 200 μM CMH spin probe, 1 mM 4-acetamidophenol (AAP), 200
μM diethylenetriaminepentaacetic acid (DTPA), and 1 U/ml HRP. Samples were incubated
at room temperature for additional 5 minutes and 50 μL mixture was loaded into a glass
capillary tube, which was then inserted into the capillary holder of a Bruker e-scan EPR
spectrometer.
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Finally, effect of BIC formation on catalase enzymatic activity was evaluated by Amplex
Red Dye Fluorescence assay. Solutions of catalase alone (250 ng/ml) or different nanozymes
were supplemented with Amplex Red Dye stock solution (10 U/mL HRP, 10 mM Ampex
Red) for 30 minute, and ROS content was measured by fluorescence at λex=563 nm,
λem=587 nm according to the manufacturer’s specifications.
Nanozyme Antioxidant Activities in Human Monocytes
Human blood monocytes seeded in 96-well plates (0.1 × 106 cells/well) were stimulated
with lipopolysaccharide (LPS, 20 ng/ml) and interferon gamma (IFN-γ, 2 μg/ml) for 24
hours to induce ROS production. Following incubation, “naked” catalase or nanozyme
solutions were added to the cells for another hour. Then cells were supplemented with
Amplex Red Dye stock solution for 30 min and ROS content was measured as described
above.
Preservation of Nanozyme Activity in BMM
Mature mouse BMM were loaded with the enzyme alone or different Z ratio nanozymes for
one hour, washed with PBS, and fresh media was added to the cells. Following one hour
incubation, the media was collected and antioxidant activity of the enzyme released from
BMM was assayed by the rate of hydrogen peroxide decomposition.
Confocal Microscopy
Monocytes grown in the chamber slides [22] were exposed to different RITC-labeled
nanozymes (Z=5) for two hours at 37 °C. Following incubation, the cells were washed with
PBS and incubated with 1 μM LysoSensor Yellow/Blue DND 160 solution for 5 minutes
according to the manufacturer’s protocol. Then, the staining solution was removed and cells
were washed two times with PBS. Labeled cells were examined by a confocal fluorescence
microscopic system ACAS-570 (Meridian Instruments, Okimos, MI) with argon ion laser
and corresponding filter set. Digital images were obtained using the CCD camera
(Photometrics) and Adobe Photoshop software.
Statistical Analysis
For the all experiments, data are presented as the mean ± SEM. Tests for significant
differences between the groups were done using a one-way ANOVA with multiple
comparisons (Fisher’s pairwise comparisons) using GraphPad Prism 5.0 (GraphPad
software, San Diego, CA). A minimum p value of 0.05 was estimated as the significance
level for all tests.
RESULTS AND DISCUSSION
Manufacture and Testing of Nanozymes
Block ionomer complexes spontaneously form upon mixing block ionomers with either
oppositely charged surfactant molecules or polyions (here polypeptide) [26]. Neutralization
of the polyion charges can lead to the formation of insoluble polyion domains, which
segregate in aqueous media. To this end, water-soluble nonionic segments (PEG) may
prevent aggregation and macroscopic phase separation. As a result, these complexes self-
assemble into particles of nanoscale size and form stable aqueous dispersions [26]. The BIC
were produced by mixing the enzyme with different block copolymers, which bind
electrostatically to each other, forming nanoparticles with the enzyme-polyion complex core
and PEG corona. Catalase from bovine liver erythrocytes used in this study is negatively
charged at physiological conditions containing 252 negatively-charged (Gln and Asp) and
240 positively-charged groups (Arg and Lys). Five different positively charged block
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copolymers were utilized for complex formation (Table 1). The effect of the length of
positively-charged block (PL) was evaluated with three poly(L-lysine)-poly(ethylene glycol)
block copolymers (PL10-PEG, PL30-PEG, and PL50-PEG) (Scheme 1). Two polymers,
PEI50-PEG and PL50-PEG evaluated effect of the structure of positively-charged block
(branched or linear for PEI50-PEG and PL50-PEG, respectively, Scheme 1). To assess
importance of the PEG corona in nanoparticle formation two pairs of block copolymers,
PL30-PEG vs. EPL, and PEI50-PEG vs. PEI50 were used (Scheme 1). Taking into account an
abundance of positively-charged groups on the catalase surface, we utilized one negatively-
charged block copolymer, poly(L-glutamic acid)-poly(ethylene glycol) (PGLU50-PEG),
allowing interactions between PGLU- block and positively charged groups of catalase
(Table 1).
First, complex formation was proved by AFM studies. Images on the positively-charged
APS mica surface revealed clear differences between naked catalase and nanozymes (Figure
1). Application of catalase alone resulted in protein aggregation and highly polydispersed-
size particles (Figure 1A). This is specific to APS mica, which is positively charged, while
catalase is negatively charged at these conditions. The observed large aggregates form
perhaps due to the electrostatic interactions between the protein and the mica surface. In
contrast, all obtained nanozymes showed small spherical particles with the narrow size
distribution (Figures 1 B-F). Typical image of PEI50-PEG/catalase complexes (Figure 1 B)
demonstrated particles with a number-averaged height of 2.4 ± 0.1 nm and diameter of 21.5
± 0.3 nm. The apparent volume was calculated as  giving a mean value
of 453.3 ± 18.5 nm3. It is worth mentioning that a volume of the catalase globule, estimated
from the molecular weight of the protein and an average protein partial specific volume
(0.73 cm3/g [27]) is ~ 300 nm3. Imaging in the air usually provides lower numbers for the
height of the sample as a result of the drying process, but higher numbers for the width, due
to the tip convolution effect. This tip-shape induced structural broadening usually results in
an overestimated volume. In this respect, the data suggest that complexes formed from
catalase and PEI50-PEG consist of one molecule of protein. Interestingly, nanoparticles
obtained with the homopolymer, PEI50 (Figure 1D) also showed no signs of aggregation,
indicating that even without the PEG corona, formation of the polyion-protein core of the
micelles served to stabilize their 3D structures. Important, BICs were stable even upon 100-
times dilution at concentrations about 0.01 mg/ml of catalase (see Materials and Methods
section). Nanoparticles formed with the negatively-charged block copolymer, PGLU-PEG
(Figure 1F), were slightly larger than those formed with positively-charged polymers. This
might be a result of a partial aggregation of negatively-charged nanozyme core on
positively-charged mica. The question remains in this case, whether the BIC complex
remain intact upon deposition on APS mica.
The hydrodynamic size (size) and surface charge (ζ-potential) of the formulations were
determined by DLS (Table 2). Particles of naked catalase showed a small size (10.3 nm)
with low polydispersity index (PdI), which was close to the theoretical diameter (10.5 nm)
of a single protein globule calculated from the molecular mass of the enzyme [28]. An
increase in the size of BICs (compared to naked catalase) accompanied by a decrease in
negative charge to nearly electroneutral for all BICs obtained with positively-charged block
copolymers confirmed the formation of complexes (Table 2). A slightly larger diameter was
recorded for the nanozyme obtained with the negatively-charged block copolymer, PGLU50-
PEG, which is consistent with what was observed for AFM (Figure 1). Moreover,
aggregation of naked catalase on positively-charged mica was now seen in freshly prepared
water solutions, as demonstrated by DLS studies (Table 2).
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Formation of BIC resulted in improved aggregation stability. Thus, substantial aggregation
of naked catalase was recorded over seven days (Table 2). In contrast, all nanozymes (with
the exception of EPL/catalase) showed stable nanoparticles with the low polydispersity
index and size. We hypothesized that the absence of a PEG corona along with lack of
additional charges on the surface of nanozyme obtained with linear EPL polymer may result
in low aggregation nanozyme stability. The latter may not be the case when branched PEI50
polymer was used (Table 2). The diameter of all nanozyme particles was below 20 nm,
suggesting that they are suitable for loading into the cell-carriers. EPL/catalase nanozyme
was least appropriate for this purpose due to the low aggregation stability in water solutions.
Cytotoxicity of Nanozymes
Possible toxic effects of polymers alone and in the complex with catalase (nanozymes) were
evaluated in BMM (cell-carriers), CATH.a neurons, and BBMEC monolayers (as an in vitro
model of BBB) (Table 3). The last cell model was used in suggestion that a portion of the
nanozyme loaded into BMM and injected intravenously may be released from the cell-
carriers in the blood stream and crosses the BBB independently [9]. As expected, BBMEC
were more resistant to the toxic effects of the catalase formulations with block copolymers
than monocytes, which are known to have greater rate of uptake than endothelial cells.
Cytotoxicity effects of nanozymes in CATH.a neurons were overall similar to the effects in
monocytes, although neurons were slightly less vulnerable than BMM. Overall, the possible
toxic effects of nanozymes in BMM (but not in endothelial cells or neurons) raise the major
concern for the cell-mediated drug delivery system.
Catalase alone did not induce any cytotoxicity in BMM and BBMEC over a wide range of
concentrations (0.03 to 6,000 μg catalase/ ml) (Table 3). The toxicity of a block copolymer
alone was greater than its corresponding nanozyme for all cell types, suggesting that the
binding of the polymer to catalase decreases its toxicity. Negatively-charged block
copolymer PGLU50-PEG (as well as its corresponding nanozyme) has significantly less
toxicity than formulations with positively-charged polymers likely linked to the overall
negative charge of the outer plasma membrane resulting in the efficient absorption and
internalization of the positively-charged block copolymers and cell-associated nanoparticles
[29]. The same reason (i.e. better interactions between longer PL blocks and cellular
membranes, as opposed to shorter PL blocks) may cause a greater polymer and nanozyme
cytotoxicity with increasing of the length of PL block (PL10-PEG < PL30-PEG < PL50-PEG,
Table 3). Thus, it is known that PEI (and especially PL) has considerable toxicity, especially
at high concentrations [30]. Surprisingly, EPL alone showed very low toxicity in a wide
range of concentrations in all cell lines, although toxic effects of the EPL-based nanozyme
were much greater, probably due to their aggregation over time (Table 2). Furthermore,
branched (PEI-) based polymers caused less toxicity in all cell types than linear (PL-) based
polymers with comparable length of a polyion block (PEI50-PEG < PL50-PEG). As
expected, addition of PEG block significantly decreased cytotoxicity of catalase
formulations with branched block copolymers (PEI50 is more toxic than PEI50-PEG
nanozymes, Table 3). In summary, the nanozymes with the least cytotoxicity are EPL-, and
PGLU50-PEG-based, followed in ascending order by PEI50-PEG, PEI50, PL10-PEG, PL30-
PEG, and PL50-PEG.
Loading and Release of Nanozymes from BMM
To achieve successful cell-mediated delivery, nanozymes should be loaded at high
concentrations and then released upon the cell’s arrival at the site of action or disease. To
this end, macrophages were exposed to a broad range of RITC-labeled nanozymes and the
enzyme cellular levels were determined. First, the accumulation kinetics of some
representative nanozymes (Z=1) shown on Figure 2 A, suggest a rapid uptake
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(approximately 30-40 minutes) of catalase into the cells. Loading capacity of nanozymes
comprising of positively-charged mono-polymers without PEG corona (PEI50- and EPL-
based) was greater than “naked” catalase, probably due to increased absorption and
internalization of positively-charged nanoparticles into BMM. Next, the nanozyme prepared
with negatively-charged block copolymer, PGLU50-PEG, was taken at almost the same
levels as “naked” catalase. Furthermore, the lowest uptake was recorded for nanozymes
based on positively-charged block-copolymers with PEG corona, especially poly-lysine with
a long cationic block, PL50-PEG. Similar results were obtained with 125I-labeled nanozyme
precipitated by TCA (Figure 2 B) confirming that observed dependences reflect actual
catalase accumulation levels. Finally, the loading capacities for different nanozymes with
various Z ratios were studied in BMM and expressed as a percentage of accumulation levels
of nanozyme vs. catalase alone (Table 4). Notably, the formation of BIC significantly
reduced the amount of nanozyme taken by the cells as the charge ratio increased (Table 4).
To this end, the most attractive nanozymes from the cell-mediated delivery standpoint are
those with low Z ratios.
Based on loading capacity, nanozymes with low Z ratios (Z=1) were chosen for release
studies. Mature BMM were pre-loaded with RITC-labeled catalase nanozymes (2 hrs) and
then cultured in fresh media for different time intervals. The kinetics of release of some
representative nanozymes (Z=1) is shown on Figure 3, indicating that loaded BMM released
catalase in the external media for at least 10 days. In consistence with accumulation studies,
the greatest levels of catalase in the media were recorded when cells were loaded with EPL-
and PEI50-based nanozymes. Nanozymes with a PEG corona showed a decreased amount of
unloaded catalase compared to “naked” enzyme. The release for all nanozymes (Z=1) was
expressed as a percentage of RITC-labeled catalase in the media when cells were loaded
with nanozyme vs. those when cells were loaded with naked catalase is shown in Table 1S.
Basically, the amount of released nanozymes ranked in the same order as for loading
capacity studies, suggesting that the more nanoparticles accumulated in the cells, the more
they released later. However, interactions with the membranes may also play an essential
role. Thus, negative particles may be released faster due to fewer interactions with cell
membranes. Polymers for BIC providing effective BMM loading and release of nanozymes
ranked in order from most to least are EPL, PEI50, PGLU50-PEG, PEI50-PEG, PL10-PEG,
PL30-PEG, and PL50-PEG.
Nanozyme Catalytic Activity
First, the effect of complex formation on catalase activity was examined in a cell-free
system by an Amplex Red assay (Figure 4). Obtained results clearly indicate that the
catalase activity was slightly increased upon formation of BIC obtained with PEG-
containing block copolymers; the larger the Z ratio in BIC, the greater the increase. Similar
effect was reported earlier for another enzyme, lysozyme, incorporated into BIC with
poly(ethylene glycol)-poly(alpha, beta-aspartic acid) block copolymers [31]. Thus, enzyme-
incorporated nanoparticles showed increased activity and stability in the water solutions.
Interestingly, in the case of mono-polymer without PEG block the catalase enzymatic
activity was decreased. This was more pronounced with the larger Z ratios (Figure 4). These
results were consistent with the data obtained by spectrophotometric assay (Table 2S). For
catalase alone (2.8 nM) the obtained apparent Michaelis–Menten constant (Km) and kcat
values were 82 mM and 2.86 × 105 s-1, respectively, that are in agreement with [32].
Nanozymes obtained with PEG-containing block copolymers showed increased catalytic
activity compared to “naked” catalase. Particularly high catalytic activity was observed for
PEI50-PEG/catalase, Z=10, probably due to the improving substrate-enzyme interactions, in
accordance with the increases of the maximum velocity (Vm, Table 2S). Oppositely,
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nanozymes without PEG corona have lower enzymatic activity than catalase alone.
Observed changes in enzymatic activity were small, but statistically significant.
Furthermore, incorporation of catalase into BIC with a block copolymer drastically
increased stability of catalase against a mixture of proteinases (pronase) (Figure 5). Thus,
50-90% of the enzyme was preserved in nanozyme formulations, when only 10% of naked
catalase was active after incubation with pronase. Increasing of Z ratio in BIC resulted in the
increase of catalase protection for PEG-containing nanozymes and decrease of protection in
non-PEG containing BIC (Figure 5). These results were in consistence with the data
obtained by EPR. The stabilization of catalase in BIC was assessed over different time
intervals (Table 5). As is seen, catalase was almost completely inactive at 150 minutes. Low
concentration of catalase (250 ng/mL) and EPR buffer are likely to cause such low stability
of the enzyme. Oppositely, catalase in PEI50-PEG, PL10-PEG, and PGLU50-PEG-containing
nanozymes was preserved up to 98% of the initial activity. The best stabilization effect was
recorded for PL10-PEG/catalase nanozyme. Overall, increasing catalase stability is crucial
for the protection of nanozymes inside the cell-carriers.
Finally, the ability of different catalase nanozymes to eliminate ROS produced by activated
BMM was examined (Figure 6). BMM incubated with LPS and γ-INF in this experiment
was utilized as a model of activated microglia in the brain with PD. The maximal activity of
nanozymes was observed for BIC obtained with positively-charged block copolymers: PLs-
PEG and PEI50-PEG. Nanozyme based on PGLU50-PEG showed almost the same activity as
catalase alone. This suggests that interaction of catalase with positively-charged block
copolymers stabilized the enzyme in a cellular system, and as a result, increased its
efficiency to deactivate ROS. No effect on the amount of ROS was found for any polymer
alone (without catalase). The increased amount of the block copolymer in the BIC (at Z
ratios ≥ 2) slightly amplified ROS decomposition rate in activated BMM (Table 3S),
probably due to both increasing enzymatic activity and stability of catalase in BIC. In
summary, the nanozymes with the highest catalytic activity are those based on positively-
charged PEG-containing BIC: PEI50-PEG, PL10-PEG, PL30-PEG, and PL50-PEG, followed
in descending order by PGLU50-PEG, and the least, EPL, and PEI50-based nanozymes.
Preservation of Catalase Enzymatic Activity in BMM
The ability of various polyion complexes to protect the enzymatic activity of catalase inside
the cell-carriers was assayed. Mature mouse BMM (grown on 24-well plates) were loaded
with catalase alone or catalase nanozyme (Z = 1, 2, and 5) for 2 hours, then cells were
washed with PBS and supplemented with fresh media. Two hours later, the media was
collected and the activity of catalase released from BMM was determined by the rate of
hydrogen peroxide decomposition (Figure 7). The results clearly indicate that all nanozymes
with PEG corona comprising of positively-charged block copolymers showed efficient
protection of catalase inside macrophages compared to catalase loaded alone. Increasing the
amount of the block copolymer in the BIC leaded to better protection of the enzyme; activity
of catalase in the complexes at Z = 5 was greater than at Z = 2 and 1. Interestingly, catalase
loaded in a polyion complex with PGLU50-PEG was degraded in BMM to an even greater
extent than “naked” enzyme (Figure 7). The most unpredictable effect was obtained with
nanozymes based on positively-charged homopolymers PEI50 and EPL without PEG corona.
Both of them showed very little, if any, protection of catalase activity. Furthermore, in
contrast to PEG-containing nanozymes, increasing the polymer amount in BIC resulted in
the decreasing of catalase activity.
We hypothesize that the protection of enzymatic activity inside carrier cells may be, at least
in part, due to a “proton sponge” effect of block copolymers. An excess of aminogroups on
the surface of the nanoparticles buffers acidification of the endocytic compartments in the
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macrophages, thereby inhibiting proteases activity and consequently decreasing degradation
of the drug [33]. In other words, a positively-charged block-copolymer might delay
phagosomal maturation and as a result prevent degradation of the enzyme in BMM.
Oppositely, PGLU50-PEG block copolymer brings additional protons, further decreasing pH
in the endosomes and resulting in even greater proteolysis of catalase. To confirm this
hypothesis, we examined the effect of different catalase nanozymes on the intracellular pH
in BMM using LysoSensor Yellow/Blue dye by confocal microscopy (Figure 8). This dye
exhibits the pH-dependent dual-emission spectra in living cells. In acidic organelles it has
predominantly yellow fluorescence, and in less acidic organelles it has blue fluorescence.
Mature mouse BMM (grown on slides) were loaded with RITC-labeled catalase alone or
nanozymes (Z = 5) for 2 hours, washed with PBS, and stained with LysoSensor dye. The
confocal images indicate that PEI50-PEG/catalase, as well as PEI50/catalase (Figures 8 B
and C), substantially increased the pH. The PL-containing nanozymes (PL10-PEG/catalase
and EPL/catalase, Figures 8 E and F) showed less effect (Figure 8A). Interestingly, loading
the cells with PGLU50-PEG/catalase nanozyme (Figure 8D) resulted in further decreases in
endosomal pH manifested in bright yellow staining that may result in faster catalase
decomposition. This could not explain the lack of the catalase protection in case of non-PEG
nanozymes, PEI50/catalase, and EPL/catalase. Hence, decreases in the enzymatic activity of
these nanozymes and increases in Km in cell-free system (Figure 4, and Table 2S) might be
a reason for this unexpected behavior. Furthermore, the trafficking and intracellular
localization of nanoparticles without PEG corona might differ from those with PEG. For
example, accumulation of nanozymes in lysosomes would result in greater catalase
degradation than in early endosomes. Detailed investigation of the entry and accumulation
mechanism for different nanozymes in BMM is ongoing in our lab. In summary, the most
efficient protection was demonstrated with positively-charged PEG-containing block
copolymers, PEI50-PEG, PL50-PEG, PL30-PEG, and PL10-PEG. The nanozymes based on
negatively-charged PGLU50-PEG, as well as homopolymers PEI50 and EPL were less
suitable.
Overall we demonstrate that the structure and composition of protective nanocontainers play
a crucial role in the therapeutic efficacy of drug formulations. This is particularly important
in the case of cell-mediated drug delivery, when nanoparticles are to be loaded into living
cells.
CONCLUSIONS
The best formulations for cell-mediated delivery of nanozymes would have limited
cytotoxicity, high loading and release capacities, and efficient preservation of catalase
enzymatic activity. To this end, we observed that nanozymes containing a negatively-
charged block copolymer (PGLU50-PEG/catalase) demonstrated low toxicity, high loading
capacity and release from BMM, however provides limited protection of the enzyme against
protease degradation inside cells. In contrast, nanozymes based on positively charged block
copolymers, especially the PLs, showed increased cytotoxicity and low loading and release
rates, but were highly protective of catalase. Importantly, nanozymes with PEG corona show
good stability in water, limited cytoxicity and efficient protection of catalase. Nonetheless,
these formulations also demonstrated decreased loading capacity and cell release. Increasing
the Z ratio in BIC leads to better protection of catalase enzymatic activity inside BMM, but
substantially reduced loadings and release. In addition, nanozymes based on mono-polymer
(without PEG corona) have higher loading and release levels, but formation of BIC with
these polymers significantly decreased catalase activity in cell-free systems and, especially,
inside the macrophages. Taken together, the most optimal nanozyme formulation is one
based on positively charged block copolymers (PEI50-PEG/catalase and PL10-PEG/catalase)
that demonstrate the most efficient protection of catalase enzymatic activity along with
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relatively high loading and release rates and limited cytotoxicity. Certainly, animal studies
of catalase nanozymes in models of human disease would provide ultimate verification.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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A pictorial scheme of different block copolymers used in this study. EPL: ε-polylisine; PEG:
Polyethylene glycol; PEI: Polyethyleneimine; PGLU: Poly(L-glutalic) acid; PL: poly(L-
lysine).
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AFM images of naked catalase (A) and different catalase nanozymes (Z=1): PEI50-PEG/
catalase (B); PL10-PEG/catalase (C); PEI50/catalase (D); PL50-PEG/catalase (E); and
PGLU50-PEG/catalase (F). Nanozymes were prepared at an enzyme concentration of 1 mg/
mL, and then diluted 100 times in PBS prior to the application on positively charged mica
(APS) for 2 minutes, washed with deionized water and dried under an argon flow. Images
revealed sharp differences between large aggregates of naked catalase and spherical particles
with size corresponding to a single catalase globule in case of nanozymes.
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Effect of block copolymer structure on catalase nanozyme uptake in BMM. A) Kinetics of
representative catalase nanozymes (Z = 1) accumulation in BMM: PL50-PEG/catalase (filled
squares); PL10-PEG/catalase (filled diamonds); PGLU50-PEG/catalase (filled triangles);
EPL/catalase (empty squares); catalase alone (empty circles). B) Accumulation of
representative catalase nanozymes (Z = 1) in BMM. Cells were treated with (A) the RITC-
labeled enzyme (1 mg/ml) in assay buffer alone or different nanozymes for various time
points or (B) 125I-labeled enzyme or nanozymes for one hour. Following incubation, (A) the
cells were washed three times with ice-cold PBS, solubilized in Triton X100 (1%), and the
amount of fluorescence was measured by fluorescent spectrophotometer (λex=488 nm,
λem=510 nm), or (B) the cellular content was precipitated by TCA, and the amount of
radioactivity in the precipitate was measured by radioactivity counter. Results from N=8
wells (± SEM) demonstrating significant increase in accumulation of nanozyme without
PEG corona; decrease of nanozyme obtained with PEG and positively-charged block
copolymer, and no effect on nanozyme comprised of PEG and negatively-charged block
copolymer, compared to “naked” catalase. Statistical significance is shown by asterisk:
p<0.05 (*), and p<0.005 (**).
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Release profile of different nanozymes from BMM: PL50-PEG/catalase (filled triangles);
PL10-PEG/catalase (filled squares); PEI50-PEG (filled diamonds); PGLU50-PEG/catalase
(crosses); catalase alone (empty diamonds). Cells were loaded with RITC-labeled catalase/
block copolymer complex (1 mg/ml, Z = 1) for two hours, washed with PBS, and incubated
with catalase-free media for various time intervals. Then, the media was collected and
fluorescence in the each sample was accounted by fluorescent spectrophotometry as
described in Figure 2 legend. The amount of the released RITC-labeled nanozyme was
normalized for protein content and expressed in μg enzyme per ml media. Results from N=8
wells (± SEM) demonstrating significant increase in release of nanozyme without PEG
corona; decrease of nanozyme obtained with PEG and positively-charged block copolymer,
and no effect on nanozyme comprised of PEG and negatively-charged block copolymer,
compared to “naked” catalase. Statistical significance is shown by asterisk: p<0.05 (*), and
p<0.005 (**).
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Effect of the amount of block copolymer in BIC on enzymatic activity of catalase in
different BIC determined by hydrogen peroxide decomposition. The catalase activities were
measured by spectrophotometry. In particular, 1-4 μL H2O2 (7.5 – 30 % v/w), and 2 μL
catalase (0.06 - 0.5 mg/ml) or various nanozymes with different Z ratios were added into a
cuvette with 1 mL PBS, and the changes in absorbance at 240 nm were monitored.
Incorporation of catalase into polyelectrolyte complex resulted in a significant increase of
catalase activity in PEG-containing nanozymes, and decrease in non-PEG nanozymes.
Values are means ± SEM (N = 8), P<0.05 (*) and P<0.005 (**) compared with naked
catalase.
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Preservation of catalase enzymatic activity in selected nanozymes. The stability of catalase
in BIC was examined upon incubation of different nanozymes (0.5 mg/ml catalase) with
trypsin (10-5 M), or pronase (2×10-1 mg/ml) for 3 hours at 37°C. Following incubation, the
aliquots were subjected for catalytic activity assessment as described in Figure 4 legend. A
residual activity of catalase is expressed as a ratio of enzyme activity after 3h of incubation
in the presence of pronase at 37°C to the initial one (at time point 0). Results from N=4
experiments (± SEM) demonstrating that incorporation of catalase into BIC with all studied
polymer (with and without PEG) drastically increased stability of catalase against a mixture
of proteinases (pronase). Statistical significance is shown by asterisk: P<0.005 (**)
compared to “naked” catalase.
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Modulation of BMM-derived ROS by catalase nanozymes (Z = 1). BMM were stimulated
with LPS (20 ng/ml) and γ-INF 2 (μg/ml) for 24 hours, and then the media was
supplemented with: catalase alone (empty circles); PL50-PEG/catalase (filled squares);
PL10-PEG/catalase (filled diamonds); PEI50-PEG (crosses); PGLU50-PEG/catalase (filled
triangles); fresh media (empty triangles). Control non-activated BMM were incubated with
fresh media (empty squares). Then cell media was supplemented with Amplex Red Dye
stock solution (10 U/mL HRP, 10 mM Ampex Red) for 30 minute, and the amount of H2O2
produced by BMM and decomposed by catalase nanozymes was measured by fluorescence
at λex=563 nm, λem=587 nm. The maximal activity of nanozymes was observed for BIC
obtained with positively-charged block copolymers. Data represent means ± SEM (N = 8).
Statistical significance of the amount of H2O2 decomposed by nanozyme or catalase,
compared to activated microglia is shown by asterisks: (*) p<0.05, (**) p<0.005.
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Preservation of enzymatic activity of catalase against degradation in BMM. “Naked”
catalase (first bar) or different nanozymes (Z = 1, 2, or 5) were loaded into BMM, cells were
washed and incubated with catalase-free media for two hours. Then, the media was
collected, and the activity of catalase released from BMM was accounted by
spectrophotometry as described in Figure 4 legend. All nanozymes with PEG corona
comprising of positively-charged block copolymers showed efficient protection of catalase
inside macrophages compared to catalase loaded alone. Increasing of the amount of the
block copolymer in the BIC leaded to better protection of the enzyme. In contrast,
nanozymes based on positively-charged monopolymers without PEG corona, or negatively-
charged block copolymer did not protect catalase inside the host cells. Data represent means
± SEM (N = 4). Statistical significance of nanozyme activity compared to catalase alone is
shown by asterisks: (*) p<0.05, (**) p<0.005.
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Effect of catalase nanozymes on endosomal acidification in BMM. Mature mouse BMM
were loaded with RITC-labeled catalase alone (A) or nanozymes (1 mg/ml, Z = 5); PEI50-
PEG/catalase (B); PEI50/catalase (C), PGLU50-PEG/catalase (D), EPL/catalase (E), or
PL10-PEG/catalase (F) for two hours, washed with PBS, and stained with 1 μM LysoSensor
dye. Confocal images indicate that nanozymes comprising of catalase and positively-
charged polymers, especially, with PEI block, substantially increased the pH in the
compartments containing catalase. Oppositely, loading of BMM with negatively-charged
containing nanozyme resulted in further decreases in endosomal pH compared to “naked”
catalase.
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A pictoral scheme for different nanozyme structures evaluated for cell-mediated drug
delivery. Three types of catalase nanozymes: Nanozyme I: contaning a negatively cherged
block copolymer (with PEG) showed low toxicity, high loading capacity and sustained
release from BMMs, but limited enzyme protection inside cell carriers; Nanozyme II:
containing positively charged block copolymers (with PEG) showed increased cytotoxicity
and low loading and release rates, but high level of nanozyme protection ; Nanozymes III:
containing monopolymers (without PEG corona) showed higher loading and release rates,
but low enzyme protection inside BMMs along with decreased catalase activity in cell-free
system. The optimal nanozyme formulation selected from nanozyme II group is based on
positively-charged block copolymers (PEI48-PEG/catalase and PL10-PEG/catalase) that
demonstrate efficient protection of catalase enzymatic activity along with relatively high
loading and release rates and limited cytotoxicity.
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Table 1
Composition of the block copolymers utilized in this work
Copolymer MW Average no. of units in ionic block a Average no. of units in non-ionic block a
PEI50 2,000 50 -
PEI50-PEG 12,000 50 227
PL10-PEG 6,600 10 114
PL30-PEG 7,730 30 114
PL50-PEG 13,200 50 114
EPL 4,740 30 -
PGLU50-PEG 13,000 50 114
a
The average numbers of units were calculated using the average molecular weighs (MW) provided by the manufacturer.
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Table 2
Diameter of different nanozyme particles measured by DLS (Z=1)
Nanozyme Size (nm) PdIa ξ-potential (mV)
Freshly prepared 7 days
catalase 10.3 ± 0.1 55.0 ± 0.2 0.1 ± 0.01 -13.2 ± 0.4
PEI50/catalase 11.7 ± 0.1 13.6 ± 0.1 0.2 ± 0.02 -7.4 ± 0.4
PEI50-PEG/catalase 14.4 ± 0.1 19.5 ± 0.2 0.2 ± 0.01 -0.82 ± 0.18
PL10-PEG/catalase 14.7 ± 0.2 345 0.2 ± 0.03 -2.8 ± 0.1
PL30-PEG/catalase 23 425 0.2 ± 0.03 n/d
PL50-PEG/catalase 16.5 ± 0.1 n/d 0.2 ± 0.01 -0.79 ± 0.005
EPL/catalase 10.9 ± 0.1 52.1 ± 0.3 0.14 ± 0.02 -4.1 ± 0.1
PGLU50-PEG/catalase 19.3 ± 0.06 n/d 0.2 ± 0.01 -13.9 ± 0.8
a
The PDI values refers to freshly prepared solutions.
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Table 3
Cytotoxicity of catalase nanozymes (Z=1) in vitro
Formulation IC50, mg/ml a
BMM BBMEC CATH.a
PEI50 0.4 ± 0.1 > 3 ± 0.1 1.7 ± 0.1
PEI50-PEG 2 ± 0.1 > 3 ± 0.1 > 3 ± 0.1
PL10-PEG 0.4 ± 0.07 1 ± 0.1 0.3 ± 0.05
PL30-PEG 0.02 ± 0.03 0.2 ± 0.02 0.045 ± 0.09
PL50-PEG 0.01 ± 0.05 0.15 ± 0.02 0.03 ± 0.06
EPL 2 ± 0.1 > 3 ± 0.1 1.5 ± 0.1
PGLU50-PEG 2 ± 0.2 > 5 ± 0.1 1 ± 0.1
PEI50/catalase 0.7 ± 0.2 > 3 ± 0.1 2 ± 0.1
PEI50-PEG/catalase >3 ± 0.05 > 3 ± 0.1 > 3 ± 0.1
PL10-PEG/catalase 0.5 ± 0.07 2 ± 0.1 0.4 ± 0.01
PL30-PEG/catalase 0.04 ± 0.001 0.18 ± 0.02 0.06 ± 0.001
PL50-PEG/catalase 0.03 ± 0.001 0.2 ± 0.05 0.02 ± 0.001
EPL/catalase 0.2 ± 0.05 > 3 ± 0.1 0.9 ± 0.1
PGLU50-PEG/catalase > 5 ± 0.1 > 5 ± 0.2 > 3 ± 0.2
a
The IC50 values refer to polymer concentration in treatment solutions. No toxicity of catalase alone was observed at concentrations up to 6 mg/
ml.
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Table 5
Preservation of catalase enzymatic activity in BIC by EPRa, b
Formulation Z ratio Incubation time
50 min 100 min 150 min
Catalase alonec 0 35.1 ± 2 6.8 ± 1 3.1 ± 0.1
PEI50-PEG/catalase 1 47.4 ± 1 (ns) 33.7 ± 1 (**) 15.8 ± 3 (**)
10 67.5 ± 4 (**) 78.9 ± 8 (**) 77.2 ± 6 (**)
20 68.9 ± 3 (**) 88.4 ± 3 (**) 81.4 ± 4 (**)
PL10-PEG/catalase 1 68.2 ± 4 (*) 61.4 ± 3 (**) 57.7 ± 4 (**)
10 88.2 ± 2 (**) 89.9 ± 3 (**) 79.0 ± 3 (**)
20 93.9 ± 6 (**) 97.4 ± 8 (**) 91.5 ± 5 (**)
PGLU50-PEG/catalase 1 49.5 ± 2 (ns) 46.0 ± 3 (**) 57.9 ± 4 (**)
10 85.8 ± 4 (**) 82.1± 3 (**) 78.4 ± 3 (**)
20 97.8 ± 5 (**) 91.2 ± 8 (**) 80.1 ± 3 (**)
a
Activity of each nanozyme is expressed as a % of residual catalase activity vs. initial activity at 0 time point
b
Statistical significance is shown by asterisk: p<0.05 (*), and p<0.005 (**) compared with residual activity of catalase alone at the same time
point.
c
Catalase concentration was 250 ng/mL
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